VPHM Financial Facts

Other operating expenses: 3.61M
Cost of sales (excluding amortization of product rights): 27.48M
See Full Income Statement

Accounts receivable, net: 61.48M
Total liabilities: 408.29M
See Full Balance Sheet

ViroPharma Inc. (VPHM) Earnings

  |   Expand Research on VPHM
Next EPS Date N/A EPS Growth Rate -4.7%
Average EPS % Beat Rate +552.1% Revenue Growth Rate +18.1%
Average % Move 1-Wk after EPS -4.4% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
10/31/13 Q313 $0.20$0.05 +$0.15$113M$113.35M = +34.4% Details
8/1/13 Q213 $0.15$0.01 +$0.14$104M$105.06M = +45.6% Details
5/1/13 Q113 $0.15$0.04 +$0.11$107M$108.47M = +83.3% Details
2/27/13 Q412 $0.10$0.03 +$0.07$106.5M$103.06M = +100.2% Details
10/25/12 Q312 -$0.07$0.02 -$0.09$91M$98.62M +83.3% Details
8/9/12 Q212 $0.09$0.12 -$0.03$94.6M$104.27M +123.2% Details
5/1/12 Q112 $0.37$0.42 -$0.05$135.8M$149.16M +129.7% Details
2/28/12 Q411 $0.61$0.42 +$0.19$145.6M$144.65M +57.6% Details